600,000 GlaxoSmithKline Inhalers Recalled

April 7, 2017
Keep Reading ↓

A recall has been announced for inhalers produced by GlaxoSmithKline, LLC (GSK). Approximately 600,000 inhalers are being recalled due to a defective delivery system.

A FDA report said that some inhalers were “out of specification results for leak rate“.The recall was classified as a Class II recall which means that “the products might cause a temporary health problem, or pose only a slight threat of a serious nature,” according to the FDA.

The affected inhalers were made in a plant in Zebulon, North Carolina. The recall is reported to be voluntary and was initiated by GSK.Full Product Details:

Full Product Details:
Ventolin HFA (albuterol sulfate) Inhalation Aerosol, 90 mcg per actuation, 200 metered inhalations, net weight 18 g inhalers, RX only. 

You can read more on this recall, by clicking here.

Leave a Comment

Your email address will not be published. Required fields are marked *